STAT - Reporting from the frontiers of health and medicine

First Opinion

By Winnie Byanyima and Chip Lyons

Health

Health

Biotech Accelerated approval, the path used to greenlight Biogen Alzheimer’s drug, has a checkered track record, critics say
Health Why is Delta such a big deal? And other burning questions about the next phase of the Covid-19 pandemic
Health Tech Happify to release prescription app to treat depression under loosened FDA rules
Biotech Seres Therapeutics’ microbiome therapy for ulcerative colitis falls short in Phase 2 trial
The Readout LOUD How concerned should we be about breakthrough coronavirus infections? One expert weighs in

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Most clinical trials failed to meet U.S. transparency requirements for recently approved drugs
Pfizer looks to widen access to Covid-19 vaccine in Africa, but advocates say it doesn’t go far enough
Up and down the ladder: The latest comings and goings

Exclusive

Health

Heavyweights

Health

Prescription Politics

Special Report

Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Health How the Covid pandemic ends: Scientists look to the past to see the future
Health Why is Delta such a big deal? And other burning questions about the next phase of the Covid-19 pandemic
The Readout LOUD How concerned should we be about breakthrough coronavirus infections? One expert weighs in
Health More than 200 people in U.S. being monitored for possible monkeypox exposure, CDC says
Health U.S. sees first cases of dangerous fungus resistant to all drugs in untreated people
In the Lab ‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims — and finding some truth